Sunday, July 12, 2020 10:59:30 AM
@HeatBiologics
"The elderly & those...suffering most...from this pandemic should know they do not need to settle for a 1-size-fits-all solution. We are working to bring...vaccine options to help those at greatest risk." CEO Jeff Wolf on the need for a "super-vaccine": http://bit.ly/2NRvlV3
#ICYMI, Jeff Wolf's thoughts on #COVID-19: "While Congress and the Administration weigh a new funding package to respond to COVID-19, they should keep in mind the special needs of America’s seniors and other immune-compromised high-risk communities": http://bit.ly/2NRvlV3
• Multiple grants received to utilize gp96 platform for various
infectious diseases
- National Institute of Health (NIH)
- Department of Defense (DoD)
- Florida Department of Health
• Heat Biologics leverages the body
Key Differentiation of gp96 Platform:
NO ANTI-VECTOR IMMUNITY ?
NO VIRAL ACTIVATION ?
NO INTEGRATION OF FOREIGN DNA ?
INTO HOST GENOME ?
ACTIVATION OF T CELLS ?
ACTIVATION OF B CELLS ?
HIGH IMMUNOGENICITY ?
INDUCTION OF MUCOSAL IMMUNITY ?
LONG-TERM MEMORY RESPONSE ?
• Leverages our proprietary gp96
platform to effectively deliver multiple
SARS-CoV-2 antigens to activate the
immune system.
• Designed to elicit long-lasting immune
response against SARS-CoV-2 virus
• We plan to collaborate with companies,
researchers, government agencies and
funding organizations to accelerate our
COVID-19 vaccine program.
--------------------------------------------------------------------
PTX-35 TNFRSF25
(mAb Solid Tumors is a billion dollar plus drug in the making
Phase 1 fully funded by grants
HS-110-NSCLC indication gp96 + CTAs
(Cell Therapy Nearing Phase 3
HS-130 OX40L solid tumors indication Nearing Phase 2
--------------------------------------------------------------------
Heat Biologics and University of Miami Developing Proprietary COVID-19 Diagnostic Test Under Collaborative Research Agreement
https://www.heatbio.com/news-media/news-releases/detail/652/heat-biologics-and-university-of-miami-developing
--------------------------------------------------------------------
Heat Biologics Announces Formation of COVID-19 Advisory Board
https://www.heatbio.com/news-media/news-releases/detail/654/heat-biologics-announces-formation-of-covid-19-advisory
--------------------------------------------------------------------
Heat Biologics Invited to Join The Alliance for Biosecurity
https://www.heatbio.com/news-media/news-releases/detail/651/heat-biologics-invited-to-join-the-alliance-for-biosecurity
--------------------------------------------------------------------
Heat Biologics Announces Collaboration with Waisman Biomanufacturing to Manufacture COVID-19 Vaccine.
https://www.heatbio.com/news-media/news-releases/detail/659/heat-biologics-announces-collaboration-with-waisman
--------------------------------------------------------------------
Heat Biologics Reports Progress on COVID-19 Efforts and Timeline of Anticipated Q2 2020 Milestones:
https://www.heatbio.com/news-media/news-releases/detail/655/heat-biologics-reports-progress-on-covid-19-efforts-and
$HTBX
Recent NHWK News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/07/2024 04:15:18 AM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 05/03/2024 08:00:06 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 05/03/2024 11:18:12 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/02/2024 12:00:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2024 12:00:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2024 12:10:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/22/2024 09:00:14 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 04/01/2024 08:52:07 PM
- Scorpius Holdings Awarded Contract in Excess of $1 Million with NIH-Funded Researcher at a Major University • GlobeNewswire Inc. • 03/19/2024 12:30:00 PM
- Scorpius Holdings Accepted as a Member of the US Government’s BioMaP-Consortium • GlobeNewswire Inc. • 03/14/2024 12:30:00 PM
- Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend] • Edgar (US Regulatory) • 03/13/2024 10:17:04 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2024 10:01:13 AM
- Scorpius Holdings, Inc. Announces Closing of Public Offering • GlobeNewswire Inc. • 03/12/2024 09:00:59 PM
- Scorpius Holdings, Inc. Announces Pricing of Public Offering • GlobeNewswire Inc. • 03/08/2024 05:20:00 AM
- Scorpius Holdings, Inc. Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 03/07/2024 09:18:08 PM
- Scorpius Holdings Estimates Greater than 375% Sequential Increase in Revenue for the Fourth Quarter of 2023 Compared to the Third Quarter of 2023 • GlobeNewswire Inc. • 03/07/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 02:34:04 PM
- NightHawk Biosciences Completes Name Change to Scorpius Holdings; Trading to Commence Under “SCPX” Effective at the Market Open Today • GlobeNewswire Inc. • 02/06/2024 01:00:00 PM
- NightHawk’s Scorpius BioManufacturing Subsidiary Announces the Promotion of Joe Payne to President and Chief Operating Officer • GlobeNewswire Inc. • 02/01/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 01:00:09 PM
- NightHawk Receives Proceeds of $3.25 Million in Connection with Sale of Non-Core Intellectual Property and Issuance of a Low Interest Bearing Note • GlobeNewswire Inc. • 01/30/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 09:30:14 PM
- NightHawk’s Scorpius BioManufacturing Subsidiary Awarded Multimillion- Dollar Contract with a Publicly Traded Biotech Company to Support its Phase 2 Clinical Program • GlobeNewswire Inc. • 01/25/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:00:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 01:30:09 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM